Veerendra Munugalavadla

Acerta Pharma, AstraZeneca Group

BIOGRAPHY

Veerendra Munugalavadla has not added Biography.

If you are Veerendra Munugalavadla and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia.

Cancer discovery 03, 2020 | Pubmed ID: 31915195

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial.

Lancet (London, England) 04, 2020 | Pubmed ID: 32305093

A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer.

Cancer Oct, 2020 | Pubmed ID: 32757302

INSTITUTIONS

Acerta Pharma, AstraZeneca Group

JOVE ARTICLES

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Paola Marco-Casanova¹,

Natalia Lukashchuk¹,

Benedetta Lombardi¹,

Veerendra Munugalavadla²,

Melanie M. Frigault³,

Elizabeth A. Harrington¹,

J. Carl Barrett³,

Andrew J. Pierce¹

¹Translational Medicine, R&D Oncology, AstraZeneca,

², Acerta Pharma, AstraZeneca Group,

³Translational Medicine, R&D Oncology, AstraZeneca

Medicine

政策

使用条款

隐私

联系我们

向图书馆推荐

JoVE 新闻简报

科研

JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案

教育

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
Faculty Site

发表

概述
发表流程
编辑部
范围和政策
同行评审
常见问题
提交稿件

图书馆员

概述
客户评价
订阅
访问权限
资源
图书馆咨询委员会
常见问题

关于 JoVE

概述
管理层
博客
JoVE Help Center